Brief: Medicenna Reports Q2 Net Loss Of $0.07 Per Share
05/11/2019 13:20
Nov 5 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS SECOND QUARTER FISCAL 2020 FINANCIAL
RESULTS
* MEDICENNA THERAPEUTICS CORP QTRLY NET LOSS OF $0.07 PER
SHARE
* MEDICENNA THERAPEUTICS CORP - MEDICENNA EXPECTS TO FILE AN
IND
FOR MDNA19 IN LATE 2020
Source text for Eikon: ID:nCNWjDzHca
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results